Simultaneous determination of atorvastatin calcium and ezetimibe in pharmaceutical formulations by liquid chromatography
A simple, precise and sensitive reverse-phase high performance liquid chromatographic (RP-HPLC) method has been developed for the quantitation of atorvastatin calcium simultaneously with ezetimibe in pharmaceutical formulations. Chromatographic separation was achieved on a 250 × 4.6 mm, 5μ Hypersil® phenyl-2 column. Eluent was monitored by absorbance at 242 nm using a mixture of 0.1 M ammonium acetate (pH 6.5) and acetonitrile in the ratio of 28:72 (v/v). Calibration plots were linear in the concentration range of 12-52 μg mL-1 for both atorvastatin calcium and ezetimibe with correlation coefficient (R2) between 0.9966 and 0.9993. The total run time is less than 5 min. The proposed method was validated by testing its linearity, recovery, selectivity, repeatability and LOD/LOQ values and it was successfully employed for the determination of atorvastatin calcium and ezetimibe in pharmaceutical tablet formulations.
Qutab, S.S.; Razzaq, S.N.; Khan, I.U.; Ashfaq, M.; and Shuja, Z.A.
"Simultaneous determination of atorvastatin calcium and ezetimibe in pharmaceutical formulations by liquid chromatography,"
Journal of Food and Drug Analysis: Vol. 15
, Article 14.
Available at: https://doi.org/10.38212/2224-6614.2433